MedTrace Logo

Ureter Identification With IRDye 800BK

NCT03387410 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-11-19

No results posted yet for this study

Summary

Phase 1/2a study, second in-man utilising IRDye800BK in ureteric identification using fluorescence throughout abdominal surgery. Study is open label, non-randomised prospective study.

Conditions

  • Ureter Injury

Interventions

DRUG

Intravenous IRDye 800BK

Fluorescence of the ureter using IRDye 800BK

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-06
Primary Completion
2018-11-01
Completion
2018-11-16

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03387410 on ClinicalTrials.gov